Medical Innovation Ventures (Mediven®) is a fast-growing diagnostics company based in Malaysia developing the GenoAmp^® and ProDetect^® series of products. Mediven collaborates closely with research institutions locally and abroad with the hope to change the paradigm of personalized medicine. We tap on research and scientific expertise to constantly come up with innovative products for the localization of personalized health through diagnostics and early detection. Mediven uses the wealth of genomic information generated on pathogens acquired through the deployment in various localized populations to create diagnostic tools that aid in the early and fast detection of infectious diseases. Our products enable differentiated strategies for better health management.

Fast, Flexible, Convenient, and Highly informative are the characteristic features of Mediven’s proprietary products. Mediven also markets and distributes other products and offers custom services for the development of molecular diagnostics and point of care tests.

Mediven was honoured by Frost & Sullivan at the 12th annual Malaysia Excellence Awards on April 14, 2016, for the Entrepreneurial Company of the Year award.